FHLC Fidelity MSCI Health Care Index ETF
Quote as of Aug 26, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 85.01 | Day Range | 84.23 – 84.79 |
| 52-Week Range | 64.30 – 85.46 | Volume | 126.31K |
| Avg Volume | 205.85K | AUM | $3.29B (Aug 27, 2026) |
| Expense Ratio | 0.08% | Yield (TTM) | 1.20% |
| NAV | 85.03 | Premium/Discount | -0.83% indicative |
| Inception | Oct 21, 2013 | Holdings | 365 |
| Issuer | Fidelity | Exchange | AMEX |
| Category | Healthcare | Index Tracked | Not stated in source data |
| CUSIP | 316092600 | ISIN | US3160926008 |
| Management | Not stated in source data | ||
About this ETF
Seeks to achieve investment results that correspond to the MSCI USA IMI Health Care Index.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +7.83% | +18.60% | +12.81% | +14.45% | +30.62% | +10.50% | +4.83% | +9.38% | +9.94% |
| Total return | +7.83% | +19.03% | +13.59% | +15.24% | +32.54% | +12.11% | +6.32% | +11.02% | +11.57% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 25, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.08% | Annual cost of a $10,000 investment | $8.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 26, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 339 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | ELI LILLY & CO | LLY | 13.50% | 385.41K | $480.6M |
| 2 | JOHNSON & JOHNSON | JNJ | 8.87% | 1.16M | $315.6M |
| 3 | ABBVIE INC | ABBV | 6.31% | 848.83K | $224.5M |
| 4 | MERCK & CO INC NEW | MRK | 5.02% | 1.19M | $178.8M |
| 5 | UNITEDHEALTH GROUP INC | UNH | 4.88% | 435.60K | $173.7M |
| 6 | AMGEN INC | AMGN | 3.23% | 258.70K | $114.8M |
| 7 | THERMO FISHER SCIENTIFIC INC | TMO | 3.15% | 178.34K | $112.1M |
| 8 | ABBOTT LABORATORIES | ABT | 2.74% | 835.83K | $97.5M |
| 9 | GILEAD SCIENCES INC | GILD | 2.46% | 595.66K | $87.4M |
| 10 | PFIZER INC | PFE | 2.14% | 2.73M | $76.4M |
| 11 | VERTEX PHARMACEUTICALS INC | VRTX | 1.88% | 122.07K | $66.8M |
| 12 | BRISTOL-MYERS SQUIBB CO | BMY | 1.85% | 979.83K | $65.9M |
| 13 | DANAHER CORP | DHR | 1.85% | 305.66K | $65.8M |
| 14 | INTUITIVE SURGICAL INC | ISRG | 1.79% | 170.45K | $63.7M |
| 15 | CVS HEALTH CORP | CVS | 1.61% | 610.54K | $57.5M |
| 16 | MEDTRONIC PLC | 0Y6X.L | 1.61% | 616.14K | $57.2M |
| 17 | STRYKER CORP | SYK | 1.52% | 165.42K | $54.2M |
| 18 | MCKESSON CORP | MCK | 1.44% | 58.78K | $51.4M |
| 19 | ELEVANCE HEALTH INC | ANTM | 1.19% | 105.42K | $42.4M |
| 20 | REGENERON PHARMACEUTICALS INC | REGN | 1.16% | 49.86K | $41.3M |
| 21 | CIGNA GROUP (THE) | CI | 1.00% | 126.53K | $35.5M |
| 22 | BOSTON SCIENTIFIC CORP | BSX | 0.98% | 713.22K | $35.0M |
| 23 | HCA HEALTHCARE INC | HCA | 0.91% | 75.10K | $32.2M |
| 24 | CENCORA INC | COR | 0.81% | 88.69K | $28.7M |
| 25 | CARDINAL HEALTH INC | CAH | 0.74% | 112.93K | $26.2M |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 1.20% | Paid (last 12 months) | $1.0200 |
| Frequency | Quarterly | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Jun 18, 2026 | Last payment | $0.2630 (Jun 23, 2026) |
| Growth 1Y | +0.29% | Growth 3Y / 5Y (ann.) | +5.16% / +5.14% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 18, 2026 | Jun 18, 2026 | Jun 23, 2026 | $0.2630 |
| Mar 20, 2026 | Mar 20, 2026 | Mar 24, 2026 | $0.2290 |
| Dec 19, 2025 | Dec 19, 2025 | Dec 23, 2025 | $0.2720 |
| Sep 19, 2025 | Sep 19, 2025 | Sep 23, 2025 | $0.2560 |
| Jun 20, 2025 | Jun 20, 2025 | Jun 24, 2025 | $0.2570 |
| Mar 21, 2025 | Mar 21, 2025 | Mar 25, 2025 | $0.2520 |
| Dec 20, 2024 | Dec 20, 2024 | Dec 24, 2024 | $0.2580 |
| Sep 20, 2024 | Sep 20, 2024 | Sep 24, 2024 | $0.2500 |
| Jun 21, 2024 | Jun 21, 2024 | Jun 25, 2024 | $0.2420 |
| Mar 15, 2024 | Mar 18, 2024 | Mar 20, 2024 | $0.2380 |
| Dec 15, 2023 | Dec 18, 2023 | Dec 20, 2023 | $0.2240 |
| Sep 15, 2023 | Sep 18, 2023 | Sep 20, 2023 | $0.2190 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 15.39% / 14.66% | Sharpe 1Y / 3Y | 1.98 / 0.661 |
| Max drawdown 1Y / 3Y | -10.38% / -16.88% | Sortino 1Y | 3.42 |
| Beta vs S&P 500 (3Y) | 0.5 | Correlation vs S&P 500 (1Y) | 0.289 |
| Downside deviation 1Y | 8.93% | Risk-free rate used | 3.72% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Aug 26, 2026. Formulas →
Liquidity
| Volume today | 126.31K | Average volume | 205.85K |
| AUM | $3.29B | Premium/Discount | -0.83% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $0.00 | 0.00% | $3.29B → $3.29B |
| 1 Week | $7.0M | +0.21% | $3.29B → $3.29B |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for FHLC
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.